"What, by the way, means potential gamble?"
You'll have to ask the person I quoted.
"It is common parlance to refer a drug accepted by FDA into phase 3 as phase 3 drug."
Is it?
"Tell me what else it could be?"
A drug that has completed Phase 2 testing.
"I see your point about of making too much out of acceptance into phase 3."
You see a point that I never made.
Here's what we were told by the Company and only the Company 3 months ago:
"Both parties agreed to an acceptable Brilacidin Phase 3 development pathway, including studying Brilacidin oral rinse effects on SOM when cisplatin is administered in higher concentrations (80-100 mg/m2) every 21 days, and at lower concentrations (30-40 mg/m2) administered weekly as part of the chemoradiation regimen."
The very next sentence was:
"Once official meeting minutes are received from the FDA, the Company expects to release more details regarding planned Phase 3 trials of Brilacidin as a novel oral SOM treatment."
I don't have to tell you what happened to the last two Phase 2 clinical trials that suffered from delays of information from the Company, information that wasn't provided as expected, do I? Neither resulted in a Phase 3 trial nor can they be called Phase 3 products , can they?
News 
Market Data 
Discover 
